Replicor Inc - Company Review
Replicor Inc - Company ReviewSummary
Replicor Inc (Replicor) is a clinical-stage biopharmaceutical company that develops antiviral technology for the cure of HBV and HDV. Its products under phase II clinical development include REP2139 and REP2165 for the treatment of Hepatitis B, Hepatitis B/D infection. The company is developing nucleic acid-based polymers (NAPs), oligonucleotides whose biochemical function is strictly dependent on the polymer chemistry of oligonucleotides. Replicor‘s NAP technology platform is also used for preventing liver re-infection in patients with chronic hepatitis C. It works in collaboration with renowned institutions such as Institut National de Transfusion Sanguine, Academic Medical Center, Cincinnati Children’s Hospital, National Microbiology Laboratory, New York Blood Center and others. Replicor is headquartered in Montreal, Quebec, Canada.
This comprehensive company report of Replicor Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.